Table 1 |
||
| Functional GO categories and KEGG pathways enriched with genes that were differentially expressed in response to a combination of PPC and saponins | ||
| GO categories and KEGG pathways | Features* | p-value† |
| Inflammatory response | 26/236 | <0.001 |
| Complement and coagulation cascade | 10/92 | 0.026 |
| Antigen processing and presentation | 9/77 | 0.022 |
| Chemokine activity | 5/6 | <0.001 |
| Valine, leucine and isoleucine degradation | 17/79 | <0.001 |
| Arginine and proline metabolism | 14/107 | <0.001 |
| Tryptophan metabolism | 12/60 | <0.001 |
| Tyrosine metabolism | 10/51 | <0.001 |
| Glycine, serine and threonine metabolism | 10/56 | <0.001 |
| Lysine degradation | 8/57 | 0.009 |
| Beta-alanine metabolism | 6/41 | 0.022 |
| Lipid metabolic process | 27/300 | 0.004 |
| Retinol metabolism | 18/79 | <0.001 |
| Fatty acid metabolic process | 14/97 | <0.001 |
| Glycerolipid metabolism | 13/68 | <0.001 |
| C21-steroid hormone metabolism | 8/49 | 0.002 |
| Sphingolipid metabolism | 7/51 | 0.018 |
| Carbohydrate metabolic process | 22/264 | 0.023 |
| Mitochondrion | 78/1091 | 0.002 |
| Lysosome | 20/183 | <0.001 |
| Protein folding | 19/180 | 0.002 |
| Peroxisome | 16/118 | <0.001 |
| Cell surface | 15/136 | 0.004 |
| Metabolism of xenobiotics | 12/55 | <0.001 |
| Glutathione metabolism | 12/69 | <0.001 |
| Glycosaminoglycan degradation | 5/32 | 0.031 |
| Extracellular space | 28/367 | 0.032 |
| Basement membrane | 9/68 | 0.008 |
| Hormone activity | 8/41 | <0.001 |
| Digestion | 7/49 | 0.014 |
* Numbers of genes among DEG and on the microarray platform.
† Yates’ corrected chi-square.
Kortner et al. BMC Veterinary Research 2012 8:101 doi:10.1186/1746-6148-8-101